Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX · NASDAQ Global Select
-$0.22 today
Vol 1.49M · Avg 1.19M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+19.93%
Period High
$56.43
Period Low
$26.85
Latest
$35.87
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.43B
Immunovant, Inc.
NASDAQ:IMVT
$7.19B
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
$5.88B
Akero Therapeutics, Inc.
AKRO
$4.50B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.17B
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$3.67B
Viking Therapeutics, Inc.
NASDAQ:VKTX
$3.56B
NewAmsterdam Pharma Company N.V.
NASDAQ:NAMS
$3.51B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.25B
Soleno Therapeutics, Inc.
SLNO
$2.76B
What is the latest CRNX filing?
The latest filing shown is 4 dated Jun 2, 2026.
How many recent filings does CRNX have?
Intrinsic Alpha currently shows 20 recent filings for CRNX.
Explore More
Continue the stock analysis
Jump to another research area for this company.